Moderate to severe glabellar lines
Clinical trials for Moderate to severe glabellar lines explained in plain language.
Never miss a new study
Get alerted when new Moderate to severe glabellar lines trials appear
Sign up with your email to follow new studies for Moderate to severe glabellar lines, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Frown lines under fire: new injection aims to erase Between-Brow wrinkles
Symptom relief Recruiting nowThis Phase 3 trial tests whether a single injection of corabotase (IPN10200) can safely reduce the appearance of moderate-to-severe frown lines between the eyebrows in adults. Participants will receive either the study drug or a placebo, then be followed for up to a year to see i…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase 3 • Sponsor: Ipsen • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
New wrinkle treatment aims to smooth frown lines in large trial
Symptom relief Recruiting nowThis phase 3 study tests an injection called IPN10200 for moderate to severe frown lines (the wrinkles between your eyebrows). About 1,300 adults will receive either the active treatment or a placebo, and some may get up to 4 treatment cycles over nearly two years. The goal is to…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase 3 • Sponsor: Ipsen • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC
-
New wrinkle treatment eveotox takes on botox in major trial
Symptom relief Recruiting nowThis phase 3 study tests a new injection called Eveotox, made from a lab-grown version of botulinum toxin, against Botox and a placebo for moderate to severe frown lines. About 669 adults aged 18 to 65 will receive one or more treatments. Researchers will check how well it smooth…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase 3 • Sponsor: JHM BioPharma (Tonghua) Co. , Ltd. • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC